Multiomics of HIV non-progressors reveals immunity behind AIDS evasion
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
SciDev3d
Success of long-lasting HIV drug hinges on pricing
Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...
healthday3d
Preexposure Prophylaxis Use Increased in Recent Years
Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oc ...
Medscape3d
Groups With Highest Unmet Need for PrEP Highlighted in Analysis
An analysis by Li Tao, MD, MS, PhD, director of real-world evidence at Gilead Sciences, and colleagues looked at statistical ...
SciDev6d
Indigenous people with HIV ‘invisible’ in Latin America
Indigenous communities in Latin America say they are missing out on life-saving HIV drugs due to a lack of representation.